OKYO Pharma Limited (OKYO) Financials

$1.12

north_east
$0.03 (2.75%)
Day's range
$1.1
Day's range
$1.15
$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25M-$30M-$30MEarning201820182019201920202020202120212022202220232023202420246%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

OKYO Income statement / Annual

Last year (2024), OKYO Pharma Limited's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, OKYO Pharma Limited's net income was -$16,825.46. See OKYO Pharma Limited,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 03/31/2024 03/31/2023 03/31/2022 03/31/2021 03/31/2020 03/31/2019 03/31/2018 03/31/2017 03/31/2016 03/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $7,506.16 $3,797.00 $2,423.01 $13,086.00 $5,971.08 $219.17 $0.00 $0.00 $0.00 $0.00
Gross Profit -$7,506.16 -$3,797.00 -$2,423.01 -$13,086.00 -$5,971.08 -$219.17 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $8,243.57 $6.34 M $1.61 M $348,347.00 $517,457.00 $3.04 M $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $573,427.00 $363,199.00 $1.05 M $1.74 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $0.00 $6.75 M $4.93 M $2.97 M $995,422.00 $1.85 M $573,427.00 $363,199.00 $1.05 M $1.74 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 -$15,811.92 -$12,427.12 $116,919.00 $48,569.00 $0.00
Operating Expenses $8,243.57 $13.19 M $6.22 M $3.37 M $1.51 M $4.54 M $1.04 M $363,269.00 $1.10 M $1.75 M
Cost And Expenses $15,749.00 $13.19 M $6.22 M $3.37 M $1.52 M $4.54 M $1.04 M $363,269.00 $1.10 M $1.75 M
Interest Income $0.00 $0.00 $0.00 $0.00 $48,065.00 $0.00 $0.00 $4,421.82 $12,358.00 $17,292.00
Interest Expense $1.05 M $96,687.00 $0.00 $1,123.00 $1,156.88 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $3,866.00 $3,797.00 $2,331.00 $13,111.00 $5,971.08 $217.82 $104.61 M $52,516.00 -$18,715.00 $0.00
EBITDA -$15,745.87 -$13.18 M -$6.22 M -$3.35 M -$1.51 M -$4.54 M $26.17 M -$363,269.20 -$1.12 M -$1.75 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$1,053.31 -$96,687.00 $0.00 $754,848.00 -$99,494.00 -$363,045.52 -$12,427.12 $121,341.00 $96,003.00 $0.00
Income Before Tax -$16,803.05 -$13.28 M -$6.22 M -$3.38 M -$1.62 M -$4.90 M -$28.27 M -$241,927.43 -$1.01 M -$1.49 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $22.42 -$12,202.00 -$786,521.00 -$24,994.00 -$76,194.00 -$171,642.18 $0.83 -$56,937.82 -$189,987.78 $6.76 M
Net Income -$16,825.46 -$13.27 M -$5.43 M -$3.35 M -$1.54 M -$4.90 M -$28.27 M -$241,927.43 -$820,171.01 -$8.26 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -0.0006 -0.6 -0.0055 -0.005 -0.0026 -0.0095 -0.0738 -0.0006 -0.0022 -0.0219
EPS Diluted -0.0006 -0.6 -0.0055 -0.005 -0.0026 -0.0095 -0.0738 -0.0006 -0.0022 -0.0219
Weighted Average Shares Out $29.34 M $22.26 M $979.21 M $672.77 M $595.47 M $513.90 M $382.88 M $381.16 M $381.16 M $377.12 M
Weighted Average Shares Out Diluted $29.34 M $22.26 M $979.21 M $672.77 M $595.47 M $513.90 M $382.88 M $381.16 M $381.16 M $377.12 M
Link